Table 2.
Sensitivity analyses: associations between blood heavy metal levels and constipation.
| Exposure | Primary analysis (model 3) OR (95% CI) | P | Sensitivity 1: Excluding eGFR OR (95% CI) | P | Sensitivity 2: Excluding extreme values OR (95% CI) | P |
|---|---|---|---|---|---|---|
| Continuous variables (log-transformed) | ||||||
| Lead | 0.496 (0.331–0.745) | .004 | 0.502 (0.336–0.750) | .003 | 0.459 (0.248–0.850) | .02 |
| Cadmium | 1.009 (0.759–1.343) | .94 | 1.013 (0.768–1.335) | .92 | 1.091 (0.653–1.824) | .71 |
| Mercury | 0.701 (0.542–0.905) | .01 | 0.700 (0.544–0.900) | .01 | 0.752 (0.583–0.969) | .03 |
| Categorical variables (quartiles) | ||||||
| Lead Q1 | Reference | – | Reference | – | – | – |
| Lead Q2 | 0.759 (0.546–1.057) | .08 | 0.761 (0.571–1.015) | .06 | – | – |
| Lead Q3 | 0.642 (0.419–0.985) | .05 | 0.646 (0.443–0.941) | .03 | – | – |
| Lead Q4 | 0.690 (0.417–1.143) | .10 | 0.695 (0.449–1.077) | .08 | – | – |
| Cadmium Q1 | Reference | – | Reference | – | – | – |
| Cadmium Q2 | 0.763 (0.544–1.071) | .09 | 0.765 (0.571–1.024) | .06 | – | – |
| Cadmium Q3 | 0.822 (0.554–1.221) | .21 | 0.824 (0.584–1.163) | .19 | – | – |
| Cadmium Q4 | 0.908 (0.539–1.528) | .60 | 0.910 (0.581–1.425) | .59 | – | – |
| Mercury Q1 | Reference | – | Reference | – | – | – |
| Mercury Q2 | 0.802 (0.579–1.109) | .12 | 0.801 (0.604–1.064) | .10 | – | – |
| Mercury Q3 | 0.835 (0.552–1.262) | .26 | 0.834 (0.582–1.195) | .23 | – | – |
| Mercury Q4 | 0.673 (0.463–0.980) | .04 | 0.673 (0.485–0.933) | .03 | – | – |
The primary analysis was fully adjusted as in model 3.
Sensitivity analysis 1 excluded adjustment for eGFR.
Sensitivity analysis 2 excluded extreme metal values (below the first percentile or above the 99th percentile) and was performed only for continuous exposure models.
ORs and 95% CIs were estimated using survey-weighted logistic regression models.
CI = confidence interval, eGFR = estimated glomerular filtration rate, OR = odds ratio.